MOSCOW (Reuters) – Russia’s RDIF sovereign wealth fund expects to receive approval for the Sputnik V vaccine against COVID-19 from the European Medicines Agency within two months, the Interfax news agency reported on Wednesday.
Reuters reported earlier on Wednesday that European Union approval of Sputnik V will be delayed because a June 10 deadline to submit data was missed, citing two people familiar with the matter.
(Reporting by Maria Kiselyova; Writing by Alexander Marrow; editing by Louise Heavens)
